Clinical Trials · NCT00002252

A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea

Name: A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/AOctreotide

Phase: N/A
Recruitment status: Completed
Sponsor: Sandoz
Enrollment: 0
Start date: Not specified
Locations: 23 sites, United States
Primary endpoint: Study in Diarrhea

View Octreotide compound reference